DK3474902T3 - Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser - Google Patents

Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser Download PDF

Info

Publication number
DK3474902T3
DK3474902T3 DK17733822.5T DK17733822T DK3474902T3 DK 3474902 T3 DK3474902 T3 DK 3474902T3 DK 17733822 T DK17733822 T DK 17733822T DK 3474902 T3 DK3474902 T3 DK 3474902T3
Authority
DK
Denmark
Prior art keywords
fluor
pharmaceutical composition
composition including
labeled
gases
Prior art date
Application number
DK17733822.5T
Other languages
English (en)
Inventor
Roig Jordi Llop
Vallejo Vanessa Gã¿Mez
Torsten Reese
FernãNdez Aitor Lecuona
Original Assignee
Asociacion Centro De Investig Cooperativa En Biomateriales Cic Biomagune
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asociacion Centro De Investig Cooperativa En Biomateriales Cic Biomagune filed Critical Asociacion Centro De Investig Cooperativa En Biomateriales Cic Biomagune
Application granted granted Critical
Publication of DK3474902T3 publication Critical patent/DK3474902T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206Administration of radioactive gases, aerosols or breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/025Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Atmospheric Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK17733822.5T 2016-06-28 2017-06-27 Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser DK3474902T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382304 2016-06-28
PCT/EP2017/065900 WO2018002079A1 (en) 2016-06-28 2017-06-27 Pharmaceutical composition comprising fluorine-18 labelled gases

Publications (1)

Publication Number Publication Date
DK3474902T3 true DK3474902T3 (da) 2021-11-01

Family

ID=56345071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17733822.5T DK3474902T3 (da) 2016-06-28 2017-06-27 Farmaceutisk sammensætning der omfatter fluor-18-mærkede gasser

Country Status (6)

Country Link
US (1) US10849994B2 (da)
EP (1) EP3474902B1 (da)
DK (1) DK3474902T3 (da)
ES (1) ES2899296T3 (da)
PT (1) PT3474902T (da)
WO (1) WO2018002079A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20230405A1 (es) * 2019-10-29 2023-03-07 Univ Johns Hopkins Profarmacos de itaconato e itaconato de metilo desarrollo o investigacion patrocinados por el gobierno
CN111574316A (zh) * 2020-04-28 2020-08-25 新华锦集团有限公司 用于制造ri标记化合物的制造方法及制造装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2401066C (en) * 2000-02-23 2010-08-10 The University Of Alberta, The University Of British Columbia, Carleton University, Simon Fraser University And The University Of Victoria, Collectively Doing Business As Triumf System and method for the production of 18f-fluoride
DE102005026253A1 (de) 2004-06-18 2006-01-05 General Electric Co. Erzeugung von 18F(F2) Fluor aus 18O(O2) Sauerstoff mit hoher Ausbeute
US8231855B2 (en) * 2010-12-28 2012-07-31 Omotowa Bamidele A Method for production of sulfur hexafluoride from sulfur tetrafluoride

Also Published As

Publication number Publication date
PT3474902T (pt) 2021-11-11
US10849994B2 (en) 2020-12-01
ES2899296T3 (es) 2022-03-10
US20190262482A1 (en) 2019-08-29
EP3474902B1 (en) 2021-08-11
EP3474902A1 (en) 2019-05-01
WO2018002079A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
EP3493799A4 (en) CANNABIS
EP3513809A4 (en) MEDICAL COMPOSITION
DK3529248T3 (da) Farmaceutiske sammensætninger
EP3493798A4 (en) CANNABIS
DK3256138T3 (da) Farmaceutiske sammensætninger omfattende meloxicam
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
DK3655017T3 (da) Farmaceutisk sammensætning
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
BR112016023628A2 (pt) composições farmacêuticas.
HRP20181479T1 (hr) Tekući farmaceutski sastav
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
DK3529240T3 (da) Farmaceutiske forbindelser
BR112018000054A2 (pt) composições farmacêuticas liofilizadas
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
PL3207149T3 (pl) Kompozycja farmaceutyczna o zwiększonej stabilności
DK3191085T3 (da) Misbrugsresistente farmaceutiske sammensætninger
DK3583943T3 (da) Farmaceutisk sammensætning
EP3402470A4 (en) STABLE PHARMACEUTICAL COMPOSITION
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3199175T3 (da) Farmaceutisk sammensætning til injektion
DK3389633T3 (da) Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat
BR112016030507A2 (pt) Compostos relacionados à vitamina d, composição farmacêutica, e kit
SMT202400478T1 (it) Composizione farmaceutica